CureVac N.V. (CVAC)

CureVac Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	402.45	495.8	811.46	1,323	30.68
Short-Term Investments	2.66	4.49	4.65	2.62	1.46
Cash & Cash Equivalents	405.11	500.28	816.11	1,325	32.14
Cash Growth	-19.02%	-38.70%	-38.42%	4022.99%	-46.99%
Receivables	14.33	6.3	18.5	1.01	15.69
Inventory	24.8	23.99	56.16	14.53	6.2
Other Current Assets	34.14	53.46	49.24	49.1	3.15
Total Current Assets	478.38	584.03	940.02	1,390	57.18
Property, Plant & Equipment	278.63	241.7	200.39	100.59	61.69
Goodwill and Intangibles	28.35	31.78	13.24	14.15	5.7
Other Long-Term Assets	2.9	2.96	4.59	6.77	6.06
Total Long-Term Assets	309.87	276.44	218.22	121.5	73.45
Total Assets	788.25	860.47	1,158	1,511	130.62
Accounts Payable	48.03	73.46	127.7	21.69	6.48
Deferred Revenue	92.68	107.31	142.1	658.05	73.52
Current Debt	5.01	4.98	3.47	3.23	2
Other Current Liabilities	40.67	-29.53	84.47	-435.34	-53.91
Total Current Liabilities	186.39	156.23	357.73	247.62	28.09
Long-Term Debt	36.82	37.11	25.42	52.04	77.14
Other Long-Term Liabilities	48.1	133.89	86.61	500.35	68.19
Total Long-Term Liabilities	84.92	170.99	112.03	552.39	145.34
Total Liabilities	271.31	327.22	469.77	800.01	173.42
Total Debt	41.82	42.09	28.89	55.28	79.15
Debt Growth	-0.62%	45.67%	-47.73%	-30.16%	102689.61%
Retained Earnings	-1,565.98	-1,305.81	-1,056.79	-645.07	-515.95
Comprehensive Income	-0.07	-0.14	-0.03	0.06	0.02
Shareholders' Equity	516.94	533.25	688.48	711.35	-42.8
Net Cash / Debt	363.29	458.2	787.22	1,270	-47.01
Net Cash / Debt Growth	-20.71%	-41.80%	-38.01%	-	-
Working Capital	291.99	427.8	582.29	1,142	29.09
Book Value Per Share	2.31	2.80	3.68	4.03	-0.24

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).